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1. Introductiixi 
The antiviral activity of 4-(59-(2,3&hydroxy~ 
propyl)adenine f(s)-DHPA] against some types of 
both RNA and DNA viruses including vaccinia, herpes 
simpIex (types 1 and 2), measles, and vesicular 
stomatitis has been demonstrated recentIy [l 3, This 
novel nucleoside analog, the sugar moiety of which is_ 
replaced by an aliphatic hain [Z], also inhibits the 
activity of adenosine deaminase (EC 35.4.4) [3] thus 
e~~c~g the antiviraf effect of adenine arabinoside 
[ 11. The experiments carried out on different cells in 
tissue culture did not show any significant effect of 
Q-DHPA either on DNA, RNA or protein synthesis 
[ 11, and no signs of toxicity were noted in mice that 
had been injected ~traperito~e~y or intravenously 
with (s)-DHPA at a dose as high as 1 g/kg. In viva, 
(5’)DIIPA is m~tabo~ca~y very stable [4], and the 
unchanged rug is rapidly excreted by urine. The 
selective antMra1 effect of (S)-DHPA substantiates 
further efforts to elucidate its biological role and 
inhibitory mechanism. 
Chick embryo fibroblasts infected in culture with 
Rous sarcoma virus (RSV) have been shown to 
acquire certain new morphologic, growth and metab- 
olic properties [S-7]. An increased glycolytic capacity, 
one of the most commonly reported alterations in 
malignant cells [8], has also been found in tissue from 
Rous sarcomas Co], in slices from cho~oa~~toic 
membranes infected with RSV [lo], and in celis from 
cultures of chicken embryo fibroblasts infected in vitro 
with RSV f6]. Enzymatic activity of certain glycolytic 
enzymes, lactate dehydrogenase (EC 1 ,I .I .27), phos- 
phoglucomutase (EC 2.7.5.1), and glucosephosphate 
isomerase (EC 5.3.1.9), is markedly higher in the 
transformed cells than in the normal tissue flo], 
In this study we have used two tra~sfo~ation 
parameters of the RSV-transformed tumor cells: 
(1) The morphological transformation of chick 
embryo fibroblasts to the round-shaped tumor 
cells; 
(2) The level of enzymatic activity of lactate dehy- 
drogenase induced in the transformed cells with 
concomitant increase of aerobic glycolysis. 
Transformation of chick fibroblasts by avian 
sarcoma viruses requires the function of a single viral 
gene (src) which is responsible for both the induction 
and rn~ten~~ of neoplastic tr~~o~ation Ill f_ 
A protein of 60 000 daltons that is apparently 
encoded in src has been isolated by immunoprecipita- 
tion from cytosol of avian and mammalian cells trans- 
formed by RSV and identified [12-141, This protein, 
which is not a structurai component of the virion, is 
thought o be responsible for RSV-induced cell trans- 
formation and has been named p6Om: [x5]. A protein 
kinase activity in ~60” has been demonstrated 
[15-l 81. This significant observation suggests hat 
virus-specific protein kinase p6F is critical in the 
tr~sfo~at~on of cells by RSV. 
Here we describe the inhibitory effect of (s)-DHPA 
on the transformation of chick embryo fibroblasts 
infected in culture with Schmidt-Ruppin strain of 
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Fig.1. Inhibition of tran~ormation by (S)-DHPA of chick embryo fibroblasts infected in culture with Schmidt Ruppin strain of 
Rous sarcoma virus Microphotographs of cultures 72 h after infection with SR-RSV. (A) Chick embryo fibroblasts (CEF) 
infected with SR-RSV and grown after infection in medium without inhibitor. Many transformed, round-shaped cells are present 
in this culture. (B) CEF infected with SR-RSV and grown after infection in medium containing 25 pg (S)-DHPA/ml. (C) CEF 
infected with SR-RSV and grown in medium containing 50 ng (S)-DHPA/ml. (D) CEF infected with SR-RSV and grown after 
infection in medium containing 100 ng (S)-DHPA/ml. Transformed cells are not present in this culture and no increase of 
aerobic gfycolysis was observed. 
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Rous sarcoma virus (SR-RSV) and present experimen- 
tal evidence that Q-DHPA inhibits enzymatic activity 
of cellular protein kinases (EC 2.7.1.37) isolated from 
the cytophsmic proteins of ROW sarcoma tissue. These 
facts suggest the possible ~h~b~to~ effect of~~-~~A 
on viraf protein kinase p6W in vivo. 
2. Materials and methods 
The cultures of chick embryo fibroblasts were 
prepared and cultivated in plastic Petri dishes in a
CO, incubator as in [ 191. The cultures were infected 
24 h after platmg with SR-RSV, 1 X 10” p.f.u./dish, 
and the infected cells were cultivated at 37°C in 
Eagle’s minimal essential medium cont~~g 10% 
inactivated calf serum and antibiotics f19f or in the 
medium containing various concentrations of
(5’).DHPA. The number of transformed cells per 
microscopic field in the infected cultures was deter. 
mined 72 h after infection, as in [20]. The extracts of 
soluble proteins were prepared 3days after infection 
from SR-RSV-infected and uninfected chick embryo 
fibroblasts and from the cells infected with SR-RSV 
and cultivated after infection in the presence of 
(5’).DHPA (100 pg/ml). The enzymatic activity of 
lactate dehydrogenase (EC 1 .l J.27) (expressed in
units/ 100 @g protein) in the extracts was determined 
by the cdorimetric method in [2 1 ], using a kit of 
chemicals for lactate dehydrogenase d termination 
(Rio-LA-test, Lachema). Protein concentration i  the 
cell extracts was determined by the method in [22], 
and in the protein kinase preparations by the method 
in [23]. 
ROW satcoma tissue was isolated from Brown 
Leghorn chickens infected with SR-RSV [20]. The 
tumor tissue was homogenized, and high-speed super- 
natant was prepared as in [24]. Chromatography of 
protein kinases i olated from Rous sarcoma on DEAE- 
Sephadex A-25 column and protein k&se assays 
were performed essentially as in [25]. Casein prepared 
according to [26] was used as substrate in protein 
kinase assays. [-y-32P]ATP (spec. act. 25 Ci/mmol), 
prepared by the method in [27], was kindly provided 
by Dr V. Pa&s. 
3, Results 
3 ,l . Inhibition by (S)-DHPA of malignant conversion 
of chick embryo fibroblasts infected with SR-RSV 
When the chick embryo ~brob~asts infected in 
culture with a high titre SR-RSV were cuhivated after 
infection in medium containing increasing concentra- 
tions of (S)-DHPA, a markedly decreased number of 
transformed cells was observed 72 h after infection in 
these cultures, depending o  the concentration of 
~~-D~A present in the medium (iig.1 f tabb I). In 
comparison with the infected cells grown in normal 
medium without inhibitor (fig.IA), there was a com- 
Table 1 
i~~b~tion by 9~~2~~~y~ox~propyl~ade~e of ~an~~rrna~on of chick embryo fibrobfasts 
infected with SRRSV and inhibition of induction of lactate dehydrogenase in the infected 
cells growing in the presence of (S)-DHPA 
Culture (S)-DHPA No. transformed Inhibition of Lactate dehydrogenase 
in medium cells in one micro- transfer- activity in cell-extract 
@g/ml) scopic field mation (%) (units/100 erg protein) 
CEF inf. SR-RSV 100 0 100 13.6 
CEF inf. SR-RSV JO 75 82.5 
CEF inf. SR-RSV 25 140 (il.3 
CEF inf. SR-RSV 0 428 0 25.5 
CEF (uninfected) - - 13.3 
Cultures of chick embryo fibrobkrsts (24 h after plating) were infected with SR-RSV as in section 2 
and cuitimted 3 days in the presence or absence of (s)-f)HPA in the medium as indicated in table I. 
The transformed cells were counted 72 h after infection under the microscope [ 201, and lactate 
dehydrogenase activities in cell extracts were determined [ 211 
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plete inhibition of cell transformation in the cultures 
growing in the presence of 100 pg (,S’)-DHPA/ml 
(fig.lD). A significant decrease in number of trans- 
formed cells was observed at the concentration of 
(S)-DHPA as low as 25 I.cg/ml (fig.lC, table 1). These 
results were reproducible in several experiments. 
Under extreme conditions (100 I.cg/ml), Q-DHPA did 
not exhibit any marked cytotoxic effect upon 
uninfected cells or untransformed cells after viral 
infection (cf. [ 11). 
Concomitantly with the inhibition of cell transfor- 
mation, Q-DHPA also inhibits the virus-induced 
metabolic alterations in the infected cells, e.g., induc- 
tion of lactate dehydrogenase (table 1) and aerobic 
glycolysis. In comparison with the untreated infected 
cells (fig.lA) where the medium was quickly acidified 
by lactic acid produced by very active aerobic glycol- 
ysis, the infected cells growing in the presence of 
100 gg Q-DHPA/ml do not acidify the medium and 
exhibit a markedly lower level of lactate dehydrogenase 
activity in the cytosol (table 1). 
However, this inhibitory effect of (QDHPA on 
the oncornavirus-specific function, i.e., morphological 
and metabolic transformation of the infected cells, 
was found to be reversible. If the infected cells grow- 
ing for 3 days after infection in medium containing 
100 pg Q-DHPA/ml were washed with normal medium 
and overlayered with normal medium containing 
1.5% agar and cultivated further at 37’C, many 
transformed, round-shaped cells appeared in this 
culture within 48 h (data not shown). Inhibition 
of cell transformation in this system thus requires a 
constant presence of the inhibitor in the medium 
(50-lOO@g (,!$DHPS/ml). This suggests that (,S)-DHPA 
does not inhibit the integration of proviral DNA into 
the cellular genome [28], nor the synthesis of viral 
RNA, but probably inhibits a virus-specific function 
responsible for cell transformation, e.g., the phos- 
phorylation of some cellular proteins catalyzed by the 
virus-specific protein kinase p6opC [15-171. 
3.2. Inhibition by IS)-DHPA of the enzymatic activity 
of protein kinases present in high-speed super- 
natant from Rous sarcoma tissue homogenate 
In a model experiment we have first studied the 
effect of Q-DHPA upon the enzymatic activity of 
cellular protein kinases present in the cytosol proteins 
of Rous sarcoma. As shown in table 2, the activity of 
protein kinases in the extract was very significantly 
inhibited by (,S)-DHPA, the inhibition being depen- 
dent on the concentration of the (@-DHPA present in 
the enzymatic assay. 
By chromatography on a DEAE Sephadex A-25 
column of the protein kinases present in the extract 
from Rous sarcoma tissue, 3 distinct protein kinase 
fractions have been isolated (fig.2) during the elution 
by linear gradient of 0.04-0.5 M ammonium 
sulfate in TGMED buffer. The protein kinases were 
Table 2 
Inhibition by Q-DHPA of enzymatic activity of protein kinases in cytosol 
proteins extracted from Rous sarcoma tissue 
Q-DHPA [ 32P]phosphate incorporated into 
(Mg/assay) casein (cpm) 




Inhibition of protein 





The assay mixture contained in 225 ~1 total vol.: 50 mM Tris-HCI buffer (pH 7.4), 
0.15 M NaCl, 10 mM MgCl,, 2 X lo6 cpm [y-32P]ATP (spec. act. 25 Ci/mmol), 
150 pg casein, 240 pg cytosol proteins extracted from Rous sarcoma tissue, and 
(S)-DHPA as indicated in the table. After 10 min incubation at 30°C the enzymatic 
reaction was stopped by addition of 3 ml ice-cold 10% trichloroacetic acid solu- 
tion containing 40 mM sodium pyrophosphate. Acid-precipitable radioactivity 
was collected on fiberglass filters GF/C (Whatman) and washed 6-times with 5 ml 
10% trichloroacetic acid. The radioactivity on the dried filters was quantitated by 
liquid scintillation counting 
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Fig.2. Chromatography of protein khrases present in high-speed 
supernatant from ROW sarcoma tissue on a DEAE-Sephadex 
A-25 column. DEAE-Sephadex A-25 column (2.5 X 20 cm) 
was equilibrated with TGMED buffer (50 mM Tris-Hc1 @H 8.0) 
containing 25% glycerol (v/v), 5 mM MgCI,, 0.1 mM EDTA 
and 5 mM dithiothreitol) containing 0.04 M ammonium 
sulfate. Proteins extracted from Rous sarcoma tissue (85 mg 
protein in 11 ml TGMED buffer) were applied on the column 
and fractions were eluted at +3”C in a linear gradient of 
0.04-0.5 M ~o~urn sulfate in ‘IGMED buffer (total 
vol. 140 ml). Fractions (4 ml) were collected (flow rate 
1 ml/m&) and aliquots 50 ~1 from each fraction were used 
for protein kinase assay, as in the legend to table 2. 
deviated PK-I (eluted by 0.1 M ~~oniu~ sulfate), 
PK-II (eluted by 0.17 M ammonium sulfate) and PK-III 
(eluted by 0.35 M ammonium sulfate). When assayed 
in the presence of 1.9 X 10e3 M (5’)DHPA, the 
enzymatic activities of the protein kinases were 
inhibited by 53% 63% and 27%, respectively, exhibit- 
ing different sensitivity to (.S’)-DHPA. Protein kinase 
PI<-11 was the most inhibited enzyme. These results 
indicate that the cellular protein kinases may be 
inhibited by (5).DHPA to a different extent. 
4. Diiussion 
Our results clearly show that 9(S)-(2,3dihydroxy- 
propyl)adenine inhibits the morphological nd metab- 
olic transformation of chick embryo fibroblasts 
infected in culture with a high titre of SR-RSV. This 
~ibition of the biological function of avian sarcoma 
virus is apparently reversible as shown by the fact 
that permanent presence of (S)-DHPA in the medium 
is necessary in order to inhibit the transformation of
RSV-infected cells. 
The fact that (S)-DHPA inhibits the enzymatic 
activity of cellular protein kinases (table 2)suggests 
that virus-specific protein kinase p6opC, which is 
responsible for the cell tr~sfo~ation by avian 
sarcoma virus [IS-181 might be inhibited by 
Q-DHPA inside the infected cells at relatively lower 
(5’).DHPA concentrations. This is supported by the 
finding that morphological transformation of chick 
embryo ~broblasts infected with SR-RSV is inhibited 
already in the presence of (5‘)DHPA at 25 pg[rnl 
(I .25 X IO4 M) (table 1). Direct experimental 
evidence of the inhibition of the virus-specific protein 
kinase p6opC by Q-DHPA is necessary in order to 
prove this hypothesis. Cellular protein kinases are 
probably not inhibited si~i~cantly by (&“)-DHPA 
in vivo at the low concentration (1.25 X 1 O4 M) of 
the inhibitor in medium. 
Furthermore we have found that the R-enantiomer, 
(R)-DHPA, is also active as inhibitor of CEF transfor- 
mation by SR-RSV, the i~bition being somewhat 
less as compared with the same molar concentration 
of (5’)DHPA, unlike the marked difference observed 
with other viruses [1,291. There is no difference in 
the transformation i hibiting potency between the 
two enantiomers and the racemic mixture (R,S)- 
DHPA. 
In a preliminary experiment we have found that 
(S)-DHPA at 100 r_lg/ml inhibits completely the pro- 
duction of virions labeled with [3H]uridine in 
cultures of chick embryo fibroblasts infected with 
SR-RSV (data not shown). The mechanism of this 
i~bition of virus replication may involve the 
inhibition of protein kinase present inside the oncorna- 
virus particles [30-321, which exhibit different 
characteristics in comparison with p6W. The possible 
effect of (s)-DHPA on these virion-associated protein 
kinases or its higher affinity to these enzymes may be 
one of the principles of the selective antiviral effect 
of this drug and deserves further experimental study. 
Acknowledgement 
The authors wish to thank Dr V. PaZes, Institute 
of Molecular Genetics, Czechoslovak Academy of 
Sciences, Prague, for the kind gift of [?““P]ATP 
preparation. 
191 
Volume 107, number 1 FEBS LETTERS November 1979 
References 
[l] De Clercq, E., Descamps, J., De Somer, P. and Holy, A. 
(1978) Science 200,563-565. 
[2] Holy, A. (1975) Coll. Czech. Chem. Commun. 40, 
187-214. 
[ 31 Schaeffer, H. J., Vogel, D. and Vince, R. (1965) J. Med. 
Chem. 8,502~506. 
[4] &k, A. and Holy, A. (1978) COB. Czech. Chem. 
Commun. 43,2082-2088. 
[5] Rubin, H. (1960) Virology 10,29-49. 
[6] Morgan, R. H. and Ganapathy, S. (1963) Proc. Sot. 
Exp. Biol. Med. 113,312-315. 
[7] Temin, H. M. (1968) lnt. J. Cancer 3,273-282. 
[S] Aisenberg, A. G. (1961) The glycolysis and respiration 
of tumors, Academic Press, New York. 
[9] Burk, D., Sprince, H., Spangeler, J. M., Kabat, E. H., 
Furth, J. and Claude, A. (1941) J. Natl. Cancer Inst. 2, 
201-240. 
[lo] Weber, G., Banerjee, G., Levine, S. and Ashmore, J. 
(1961) J. Natl. Cancer Inst. 27,869-873. 
[ 111 Vogt, P. K. (1977) in: Comprehensive Virology 
(FraenkelConrat, H. and Wagner, R. eds) pp. 341-455, 
Plenum Press, New York. 
[ 121 Brugge, J. S. and Erikson, E. (1977) Nature 269, 
346-348. 
[ 131 Purchio, A. F.,Erikson,E., Brugge, J. S. and Erikson, R. 
(1978) Proc. Natl. Acad. Sci. USA 75,1567-1571. 
[14] Beemon,K.andHunter,T.(1978)J.Virol.28,551-566. 
[ 151 Collett, M. S. and Erikson, R. L. (1978) Proc. Natl. 
Acad. Sci. USA 75,2021-2024. 
[ 161 Levinson, A. D., Oppermann, H., Levintow, L., Varmus, 
H. E. and Bishop, J. M. (1978) Cell 15,561-572. 
[ 171 Rubsamen, H., Friis, R. R. and Bauer, H. (1979) Proc. 
NatL Acad. Sci. USA 76,967-971. 
[ 181 Sefton, B. M., Hunter, T. and Beemon, K. (1979) 
J. Virol. 30,311-318. 
[ 191 Kaia, J. (1968) Folia Biol. (Praha) 14,249-265. 
[20] Mach, O.and K&a, J. (1971) Folia Biol. (Praha) 17, 
65-72. 
[21] Babson, A. L. and Phillips, G. E. (1965) Clin. Chim. 
Acta 12,210-215. 
[22] Bradford, M. M. (1976) Analyt. Biochem. 72,248-254. 
[23] Lowry, 0. H., Rosebrough, N. J., Farr, A. L. and 
Randall, R. J. (1951) J. Biol. Chem. 193,265-275. 
[24] Keller, R. K., Chandra, T., Schrader, W. T. and 
O’Malley, B. W. (1976) Biochemistry 15,1958-1967. 
[25] Desjardins, P. R., Lue, P. F., Liew, C. C. and Gornal, 
A. G. (1972) Canad. J. Biochem. 50,1249-1259. 
[26] Reiman, E. M., Walsh, D. A. and Krebs, E. G. (1971) 
J. Biol. Chem. 246,1986-1995. 
[27] Glynn, I. M. and Chappell, J. B. (1964) Biochem. J. 
90,!47-149. 
(281 Varmus, H. E., Vogt, P. K. and Bishop, J. M. (1973) 
Proc. Natl. Acad. Sci. USA 70,3067-3071. 
[29] De Clercq, E. and Holy, A. (1979) J. Med. Chem. 22, 
510-513. 
[30] Hizi, A., Wunderli, W. and Joklik, W. K. (1979) Virol- 
ogy 93,146-158. 
[31] Houts, G. E., Miyagi, M., Ellis, C., Beard, D., Watson, 
K. F. and Beard, J. W. (1978) J. ViroL 25,546-552. 
[ 321 Rubin, C. S. and Rosen, 0. M. (1975) Annu. Rev. Bio- 
chem.44,831-887. 
192 
